Hematology/Oncology

Top Story

Association of Community Cancer Centers names 2017-2018 president

April 22, 2017

Mark S. Soberman , MD, MBA, FACS, has been elected president of the Association of Community Cancer Centers for the 2017-2018 term.

Soberman — medical director for the oncology service line and chief physician executive for Monocacy Health Partners at Frederick Regional Health System — called the association “the leading education and advocacy organization for the multidisciplinary cancer care team.”

Meeting News

Sorafenib, selective internal radiation yield similar survival in HCC

April 22, 2017
AMSTERDAM — Selective internal radiation therapy failed to best Nexavar in overall survival but did yield improvements in other parameters, including quality of…
In the Journals Plus

Women considering double mastectomies satisfied with surgery choices

April 21, 2017

Biosimilars to rituximab, etanercept recommended for approval in Europe

April 21, 2017
The Committee for Medicinal Products for Human Use has recommended approval of biosimilars by Sandoz for rituximab and etanercept for the same indications as the…

Longitudinal study launched to help determine transition from health to disease

April 21, 2017
Verily Life Sciences LLC announced the launch of a 4-year study in partnership with Duke University School of Medicine and Stanford Medicine to gain a better…
More News Headlines »
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Video
Meeting News

VIDEO: Cappelli discusses autoimmune complications from cancer therapy

April 8, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement